Plexian AB (publ)
PLEX.ST
Stockholm Stock Exchange0.03
SEK
-0.01
- -
Plexian AB (publ)
PLEX.ST
(Stockholm Stock Exchange)
Recent
price
0.03
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- Plexian AB (publ) (PLEX.ST) operates as a Sweden-based fintech company focused on electronic payments and sales-driving loyalty solutions. The company develops and offers the Edge Visa payment platform, a transaction-based loyalty system that combines smart payment cards, mobile apps, and data-driven personalization to generate targeted offers based on customer behaviors and open banking opportunities; data-powered loyalty programs utilizing insights from past transactions to foster long-term customer relationships; and customized stablecoin solutions for enhanced loyalty and digital currency applications. Its business model emphasizes converting partner company members, such as those from Fitness24Seven, into Edge Visa users to connect consumers with businesses through integrated payment and reward systems. Founded in 2017 and headquartered in Malmö, Plexian primarily serves clients in the Nordic region, targeting sectors like fitness, retail, and services seeking improved customer retention via technology-driven loyalty tools. In a major development, Plexian AB (publ) was declared bankrupt by the Malmö District Court in April 2024, leading to its delisting from Nasdaq First North Growth Market; this followed observation status earlier that year due to board changes and operational challenges. Prior to bankruptcy, the company had pursued expansions including agreements with partners like Fitness24Seven and developments in stablecoins via related entity PlexChain AB, though no recent funding rounds, acquisitions, or new product launches were reported in the last 1-2 years.